ストックスクリーナーアプリを入手
1.19
0.83%
-0.01
プレマーケット:
1.17
-0.02
-1.68%
前日終値:
$1.20
開ける：
$1.19
24時間の取引高:
600.57K
Relative Volume:
0.74
時価総額：
$36.74M
収益：
$680.00K
当期純損益:
$-75.33M
株価収益率:
-0.1923
EPS:
-6.1898
ネットキャッシュフロー:
$-57.38M
1週間 パフォーマンス:
+9.17%
1か月 パフォーマンス:
+4.39%
6か月 パフォーマンス:
-33.89%
1年 パフォーマンス:
-27.44%
1日の値動き範囲:
$1.18
$1.26
1週間の範囲:
$1.08
$1.27
52週間の値動き範囲:
$1.01
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
名前
Bioxcel Therapeutics Inc
セクター
電話
203-643-8060
住所
555 LONG WHARF DRIVE, NEW HAVEN, CT
Compare BTAI vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
1.19 | 35.82M | 680.00K | -75.33M | -57.38M | -6.1898 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-17 | 開始されました | Rodman & Renshaw | Buy |
| 2024-02-21 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-15 | ダウングレード | Mizuho | Buy → Neutral |
| 2023-07-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-03-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-12-01 | アップグレード | Goldman | Sell → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-06 | 繰り返されました | BofA Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-09 | 開始されました | Berenberg | Buy |
| 2021-02-01 | 開始されました | UBS | Buy |
| 2020-10-30 | 開始されました | Goldman | Buy |
| 2020-09-02 | 開始されました | Jefferies | Buy |
| 2020-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-04 | 開始されました | Guggenheim | Buy |
| 2020-04-01 | 開始されました | BofA/Merrill | Buy |
| 2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-12 | 開始されました | SunTrust | Buy |
すべてを表示
Bioxcel Therapeutics Inc (BTAI) 最新ニュース
BTAI News | BIOXCEL THERAPEUTICS INC (NASDAQ:BTAI) - ChartMill
BTAI Stock Gained 5% TodayWhat's The Latest On Its Opioid Withdrawal Treatment? - Stocktwits
Attention BioXcel Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against BioXcel Therapeutics, Inc. (BTAI) and Encourages Investors to Contact the Firm - TMX Newsfile
What makes BioXcel Therapeutics (BTAI) a new buy stock - MSN
BioXcel Deadline Alert - TMX Newsfile
What Makes BioXcel Therapeutics (BTAI) a New Buy Stock - Yahoo Finance
BioXcel Shareholder Action Reminder - TMX Newsfile
BTAI Technical Analysis & Stock Price Forecast - Intellectia AI
BioXcel presents data on at-home agitation treatment trial By Investing.com - Investing.com India
BioXcel Therapeutics Presents New Data from Serenity At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia - marketscreener.com
BioXcel presents data on at-home agitation treatment trial - Investing.com
BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting - The Manila Times
BioXcel Therapeutics Presents New Data from SERENITY - GlobeNewswire
BioXcel Therapeutics | 424B5: Prospectus - Moomoo
BioXcel Therapeutics Company Profile & Introduction - Moomoo
BioXcel Therapeutics CEO Mehta sells $21,108 in company stock By Investing.com - Investing.com Nigeria
BioXcel Therapeutics chief legal officer sells $7,111 in stock By Investing.com - Investing.com Nigeria
BioXcel CFO Richard Steinhart sells $7,426 of stock By Investing.com - Investing.com India
BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock By Investing.com - Investing.com Nigeria
BioXcel Therapeutics CEO Mehta sells $21,108 in company stock - Investing.com India
BioXcel CFO Richard Steinhart sells $7,426 of stock - Investing.com UK
BioXcel Therapeutics chief legal officer sells $7,111 in stock - Investing.com
BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock - Investing.com
BioXcel Therapeutics (BTAI) CSO exercises 17,500 RSUs, sells 6,845 shares for tax payment - Stock Titan
BioXcel Therapeutics (BTAI) executive sells shares after RSU vesting for taxes - Stock Titan
BioXcel (BTAI) CFO exercises 17,500 RSUs and sells 6,845 shares for taxes - Stock Titan
BioXcel Therapeutics (BTAI) CEO sells shares to cover RSU tax obligations - Stock Titan
BioXcel Shareholder Notice - TMX Newsfile
BioXcel Therapeutics (BTAI) Form 144: 19,419 RSUs vested, 30.9M shares outstanding - Stock Titan
BioXcel Therapeutics (NASDAQ: BTAI) notice to sell 6,560 vested restricted shares - Stock Titan
BioXcel Therapeutics (BTAI) Rule 144: 6,845 shares from vested RSUs - Stock Titan
[144] BioXcel Therapeutics, Inc. SEC Filing - Stock Titan
Is BioXcel Therapeutics (BTAI) Overvalued After Q1 2026? EPS Not - GuruFocus
BioXcel Therapeutics, Inc. (BTAI) reports Q1 loss, lags revenue estimates - MSN
Is BioXcel Therapeutics (BTAI) Overvalued After Q1 2026 Results? - GuruFocus
BioXcel Therapeutics Reports Q1 2026 Results, FDA Accepts IGALMI sNDA for At-Home Use, and Explores Strategic Options - Minichart
BioXcel Therapeutics (BTAI) Reports First Quarter Revenue and Re - GuruFocus
BioXcel Therapeutics 1Q Loss $12.7M >BTAI - Moomoo
Press Release: BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - Moomoo
Armistice Capital reports 7.05% stake in BioXcel (NASDAQ: BTAI) - Stock Titan
Bioxcel Therapeutics Inc (BTAI) 財務データ
収益
当期純利益
現金流量
EPS
Bioxcel Therapeutics Inc (BTAI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Rodriguez Javier | See Remarks |
May 20 '26 |
Sale |
1.08 |
6,560 |
7,111 |
26,803 |
| Steinhart Richard I | Chief Financial Officer |
May 20 '26 |
Sale |
1.08 |
6,845 |
7,427 |
26,300 |
| Mehta Vimal | CEO and President |
May 20 '26 |
Sale |
1.09 |
19,419 |
21,108 |
69,598 |
0.95%
1.13%
大文字化:
|
ボリューム (24 時間):